Health researchers in Africa are joining forces with experts at The University of Queensland in the quest for a new global drug development.
The University of Queensland (UQ) and African Network for Drugs and Diagnostics Innovation (ANDI) signed a Memorandum of Understanding (MoU) to facilitate Drug Discovery in Africa.
Details on CO-ADD at BIO 2016 Convention, San Francisco, USA this June
Researchers from The University of Queensland (UQ) are advancing their mission to discover new antibiotics capable of combating multi-drug resistant bacterial infections after signing an agreement to screen the entire French National Chemical Library.
Le programme de drug discovery CO-ADD (Community for Open Antimicrobial Drug Discovery, Université du Queensland, Brisbane, Australie) et l’initiative ENABLE de l’IMI (Innovative Medicines Initiative, Bruxelles, Europe) joignent leurs forces pour découvrir de nouveaux antibiotiques potentiels contre les infections bactériennes antibiorésistantes.
The Community for Open Antimicrobial Drug Discovery (CO-ADD) and the Innovative Medicines Initiative (IMI) ENABLE project have aligned to develop potential new antibiotics against multi-drug resistant bacterial infections.
